10:15 AM EDT, 03/27/2024 (MT Newswires) -- Medtronic ( MDT ) said Wednesday that the US Food and Drug Administration approved its transcatheter aortic valve replacement system to treat symptomatic severe aortic stenosis, a heart valve disease.

The company said the Evolut FX, slated to launch this summer, is approved for all risk categories in the US.

Shares of the company were more than 2% higher in recent trading.

Price: 85.69, Change: +1.99, Percent Change: +2.38